The role of ZIKV E protein in immune evasion has been demonstrated through experiments using the human glial cell line SNB19, where Atranorin, a secondary metabolite of lichens, inhibited ZIKV infection by attenuating the activation of the IFN signaling pathway through direct targeting of the E protein [123]. Here, IFNA1 is linked to Zika virus infectious disease.